Reimagining Humanity

As the science of paleoanthropology developed, human evolutionary trees changed as much as the minds that constructed them.

Written byIan Tattersall
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

PALGRAVE MACMILLAN TRADE, JUNE 2015Before the mid-1900s, human fossils were for the most part studied and pronounced upon by specialists in human anatomy. Based in medical schools, these researchers were exquisitely attuned to variation within Homo sapiens, but were largely unconcerned with the riotous diversity of species out there in the living world. Ignorant of taxonomic norms, they branded newly discovered hominin fossils with new Latin names, much as they gave each of their children a separate name. In this way, throughout the first half of the 20th century the rapidly expanding paleoanthropological literature became littered with formal names—even though many of the freshly unearthed fossils actually belonged to species that had already been described.

I write about this crucible of discovery and folly in my new book, The Strange Case of the Rickety Cossack.

The haphazard application of species names to every new hominin fossil was a practice that could not continue indefinitely. And in 1950 the ornithologist Ernst Mayr, one of the fathers of the Evolutionary Synthesis, took it upon himself to lecture the paleoanthropologists on the error of their ways. The Synthesis was an elaboration of evolutionary theory that saw most evolutionary change as the gradual accumulation, via natural selection, of small genetic innovations within ancestor-descendant sequences. So Mayr depicted human evolution as the slow modification of a single lineage culminating in Homo sapiens. Among the fifteen hominin genera then described, Mayr said, there was in reality ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies